OSPAMOX
250MG/5ML POR PLV SUS 60ML
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Resumption of marketing | 19.03.2020 | |||
Interruption of marketing | 27.01.2020 |
0019751, 0032557, 0032558, 0032559, 0062049, 0062050, 0062051, 0062052, 0062053 Lék v jiné lékové formě a síle (dle indikací) |
Capacity/distribution reasons | 21. týden |
All reports are available in the Overview.